What is Parol?
Parol is an advanced AI-driven platform designed to revolutionize the creation of medical reports. By listening to doctor-patient conversations, Parol accurately generates comprehensive medical documentation in both Romanian (RO) and English (EN). This technology addresses a critical need for efficiency and accuracy in clinical settings, aiming to reduce administrative burdens on healthcare professionals and improve the quality of patient records. The company's focus on AI for medical reporting positions it at the intersection of artificial intelligence and healthcare innovation.
How much funding has Parol raised?
Parol has raised a total of $2.3M across 2 funding rounds:
Angel/Seed
$1.3M
Other Financing Round
$1M
Angel/Seed (2024): $1.3M with participation from Gapminder VC
Other Financing Round (2025): $1M led by Gapminder VC
Key Investors in Parol
Gapminder VC
GapMinder is a venture capital fund focused on investing in early-stage startups in the AI, Deeptech, and SaaS sectors, particularly within the B2B space. They aim to support ambitious entrepreneurs from the South Eastern Europe region and its diaspora, providing not only financial backing but also strategic guidance.
What's next for Parol?
With substantial enterprise-level backing and a recent strategic investment, Parol is poised for significant expansion and further development. The company's trajectory suggests a focus on scaling its AI-powered medical reporting solutions across broader markets. Future endeavors will likely involve enhancing the platform's capabilities, potentially expanding language support, and deepening its integration into existing healthcare workflows. This strategic financing will empower Parol to solidify its position as a leader in AI-driven health-tech, driving innovation in medical documentation and patient care.
See full Parol company page
